survival of patients with ovarian cancer in central and northern denmark, 1998–2009

Clicks: 183
ID: 133511
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #30 of 42 articles by views in journal of industrial and engineering chemistry

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Anne Fia Grann1, Mette Nørgaard1, Jan Blaakær2, Erik Søgaard-Andersen3, Jacob Bonde Jacobsen11Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark; 3Department of Gynaecology and Obstetrics, Aalborg University Hospital, Aalborg, DenmarkObjective: To examine time trends of survival and mortality of ovarian cancer in the central and northern Denmark regions during the period 1998–2009.Study design and setting: We conducted a cohort study including women recorded with a first-time diagnosis of ovarian cancer in the Danish National Registry of Patients (DNRP) between 1998 and 2009. Patients were followed for survival through the Danish Civil Registration System. We determined survival stratified by age, and used Cox proportional hazard regression analyses to obtain mortality rate ratios (MRRs) to assess changes over time.Results: We found no improvement in overall ovarian cancer survival between 1998 and 2009. One-year survival was 71% in 1998–2000 and 68% in 2007–2009. Three-year survival declined from 48% in 1998–2000 to 46% in 2007–2009 (predicted), and 5-year survival declined from 40% in 1998–2000 to 37% in 2007–2009 (predicted). Compared with the period 1998–2000, the age-adjusted 1-year MRR was 1.05 (95% confidence interval CI: 0.86–1.28) for the period 2007–2009, and the predicted age-adjusted 3- and 5-year MRRs were 0.96 (95% CI: 0.83–1.12) and 0.99 (95% CI: 0.86–1.14), respectively. Results are not adjusted for tumor stage as this information was not available. We also observed a decline in the annual number of incident ovarian cancer patients during the study period, most pronounced in the youngest age group.Conclusion: The survival of ovarian cancer patients did not improve during the study period. This lack of improvement contrasts with the national cancer strategies implemented during this last decade, focusing on improving the survival of ovarian cancer patients.Keywords: ovarian neoplasm, outcome research, MRR, mortality rate ratio
Reference Key
af2011clinicalsurvival Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Grann AF, N&oslash, rgaard M, Blaak&aelig, r J, S&oslash, gaard-Andersen E, Jacobsen JB
Are you one of these authors? Claim your profile
Journal journal of industrial and engineering chemistry
Year 2011
DOI
DOI not found
URL
http://www.dovepress.com/survival-of-patients-with-ovarian-cancer-in-central-and-northern-denma-a7917
Keywords
Infectious and parasitic diseases

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.